Acute disseminated encephalomyelitis (ADEM) is a monophasic autoimmune demyelinating
disease of the central nervous system that typically follows a febrile infection or a …

Background: Multiple sclerosis (MS) is a complex disease with new drugs becoming
available in the past years. There is a need for a reference tool compiling current data to aid …

Background Ofatumumab, a subcutaneous anti-CD20 monoclonal antibody, selectively
depletes B cells. Teriflunomide, an oral inhibitor of pyrimidine synthesis, reduces T-cell and B-…

Patients with multiple sclerosis acquire disability either through relapse-associated worsening
(RAW) or progression independent of relapse activity (PIRA). This study addresses the …

Human tumors frequently escape immune destruction, despite the presence of cyototoxic T
cells (CTL) recognizing tumor‐associated antigens (TAA). We have previously shown that …

Human glioblastoma is a highly lethal tumor that is known for its immune inhibitory capabilities.
B7-homologue 1 (B7-H1), a recently identified homologue of B7.1/2 (CD80/86), has been …

HLA-G is a nonclassical MHC molecule with highly limited tissue distribution that has been
attributed chiefly immune regulatory functions. Glioblastoma is paradigmatic for the capability …

Rasmussen's encephalitis is a progressive epileptic disorder characterized by unihemispheric
lymphocytic infiltrates, microglial nodules, and neuronal loss leading to the destruction of …

T cells contribute to the pathophysiology of ischemic stroke by yet unknown mechanisms.
Mice with transgenic T-cell receptors (TCRs) and mutations in costimulatory molecules were …

Abstract Treatment of multiple sclerosis (MS) is challenging: disease-modifying treatments (DMTs)
must both limit unwanted immune responses associated with disease initiation and …